Stardust Powder Coatings Announces Antiviral Coating Success

Stardust Powder Coatings (L’Aquila, Italy) has successfully tested its first antiviral coating against standard protocol ISO21702, which the company says should indicate the coating’s effectiveness against human Coronavirus NL63.

In March, Stardust Powder Coatings – a company specializing in the production of high added-value powder coatings that find application in many sectors – began developing and testing antiviral coatings. Its first successful result has arrived with the Metalgrey 1050k metallic epoxy powder, which sees wide use in the architecture and design sector.

The Virology Research Services (London, U.K.) laboratory conducted the tests, and continues to do so for other grades of powder coatings from Stardust.

“To meet the growing demand for coatings that can ensure greater surface hygiene, we have undertaken an intense research and development process that has led to the launch of Guardian AM, a range of antimicrobial coatings with integrated silver-ion technology which, in just two hours, can reduce up to 99.5 percent of the bacterial load on a product protected with the coating," Guido Pozzoli, CEO of Stardust Powder Coatings, explains. “But we didn't want to stop there. So, we immediately set to work to bring the protective effectiveness of our coatings to the next level in order to provide an antiviral property as well. The goal of Stardust is in fact to expand the range of Guardian AM coatings, combining antimicrobial and antiviral properties for any color, finish and for any field of application. This will further improve the permanent hygiene of surfaces and achieve an even more effective hygienic defense, alongside cleaning and hand hygiene."